Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
